Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Camitta

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Leukemia|July 29, 2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821M Chang, S C Raimondi, Y Ravindranath, et al.
Bone Marrow Transplantation|November 1, 1988
Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group studyJ Graham-Pole, B Camitta, J Casper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
The New England Journal of Medicine|July 31, 1986
Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group StudyG K Rivera, G Buchanan, J M Boyett, et al.
Leukemia|September 20, 2000
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group StudyM B Harris, J J Shuster, J Pullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group studyD H Mahoney, D Strother, B Camitta, et al.
Blood|May 1, 1995
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasiaJ Casper, B Camitta, R Truitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group studyB Camitta, D Mahoney, B Leventhal, et al.
Transplantation Proceedings|February 1, 1995
Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipientsL A Baxter-Lowe, C Keever, D Dinauer, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Leukemia|July 29, 2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821M Chang, S C Raimondi, Y Ravindranath, et al.
Bone Marrow Transplantation|November 1, 1988
Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group studyJ Graham-Pole, B Camitta, J Casper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
The New England Journal of Medicine|July 31, 1986
Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group StudyG K Rivera, G Buchanan, J M Boyett, et al.
Leukemia|September 20, 2000
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group StudyM B Harris, J J Shuster, J Pullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group studyD H Mahoney, D Strother, B Camitta, et al.
Blood|May 1, 1995
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasiaJ Casper, B Camitta, R Truitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group studyB Camitta, D Mahoney, B Leventhal, et al.
Transplantation Proceedings|February 1, 1995
Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipientsL A Baxter-Lowe, C Keever, D Dinauer, et al.
Pageof 8